A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 110
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : HERS
Long Form : Heart and Estrogen/progestin Replacement Study
No. Year Title Co-occurring Abbreviation
2016 [Hormone replacement therapy and cardio-vascular disease]. ERAS, MWS, WHI
2014 Menopausal hormone therapy and cardiovascular disease risk: utility of biomarkers and clinical factors for risk stratification. CVD, HT, WHI
2014 [Hormone replacement therapy in menopause]. EPT, ET, HT, RCTs, WHI
2013 Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease. CVD, KEEPS, MHT, RCTs, SERMs, VSM, WHI
2013 Menopausal hormone therapy for the primary prevention of chronic conditions. U.S. Preventive Services Task Force recommendation statement. HRT, RCTs, USPSTF, WHI
2012 Placebo adherence and mortality in the Heart and Estrogen/Progestin Replacement Study. ---
2011 Vascular effects of estrogenic menopausal hormone therapy. CEE, CVD, MHT, Post-MW, Pre-MW, RCTs, VSM, WHI
2010 Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease. CVD, ERs, MHT, Post-MW, Pre-MW, RCTs, VSM, WHI
2010 Self-reported changes in providers' hormone therapy prescribing and counseling practices after the Women's Health Initiative. HT, OB/GYN, WHI
10  2009 Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial. AF, CI
11  2008 ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease. ---
12  2008 Estrogen-mediated protection in myocardial ischemia-reperfusion injury. WHI
13  2008 Health-related quality of life following coronary artery bypass graft surgery in post-menopausal women. CABG, DASI, HRQoL
14  2008 Sex steroids and vascular responses in hypertension and aging. CVD, ERs, HT, NO, VSM
15  2008 Trend in incidence of osteoporosis-related fractures among 40- to 69-year-old women: analysis of a large insurance claims database, 2000-2005. ---
16  2007 Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system? CHD, CVDs, HRT, WHI
17  2007 Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease. WHI
18  2007 Planning for closeout--from Day One. ---
19  2007 Role of oestrogen in the central regulation of autonomic function. ---
20  2007 Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. CVD, ERs, HRT
21  2007 Sex hormones, vascular function and the outcome of hormone replacement therapy in cardiovascular disease. HRT
22  2006 Continuation of hormone replacement therapy during acute myocardial infarction after the women's health initiative study. Is it the time for change? CHD, HRT, MI, WHI
23  2006 Hormonal therapy: does it increase or decrease cardiovascular risk? CAD, HT, WHI
24  2006 Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. CVD, HRT, WHI
25  2006 Scientific evidence changes prescribing practice--a comparison of the management of the climacteric and use of hormone replacement therapy among Swedish gynaecologists in 1996 and 2003. HRT, WHI
26  2006 [Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)]. HRT, TNF-alpha, WHI
27  2005 Changes in women's attitudes towards and use of hormone therapy after HERS and WHI. WHI
28  2005 Hormone replacement therapy and colorectal cancer: an update. HRT, RR, WHI
29  2005 KEEPS: The Kronos Early Estrogen Prevention Study. WHI
30  2005 Menopausal hormone therapy: currently no evidence for cardiac protection. AHA, WHI
31  2005 Sexual activity and function in postmenopausal women with heart disease. ---
32  2005 The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the Heart and Estrogen-Progestin Replacement Study (HERS). CHD, UA
33  2005 Where are we with postmenopausal hormone therapy in 2005? WHI
34  2004 Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. WHI
35  2004 Clinical monograph: hormone replacement therapy. CHD, FDA, HRT, WHI
36  2004 Creatinine levels and cardiovascular events in women with heart disease: do small changes matter? CHD, CI, RH
37  2004 Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit. CEE, HRT, max, MPA, NETA, WHI
38  2004 Do lipid profiles of postmenopausal women under oral hormone replacement therapy remain stable or reveal a multiphasic course in time? CEE, HDL, LDL, MPA
39  2004 Hormone replacement therapy and cardiovascular disease: lessons from a monkey model of postmenopausal women. ERT, HRT, WHI
40  2004 Hormone replacement therapy and stroke: clinical trials review. WEST, WHI
41  2004 Hormone therapy and the cardiovascular system: the critical role of progestins. CEE, HRT, MPA, WHI
42  2004 Predictors of heart failure among women with coronary disease. ---
43  2004 Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS). CI, HR, PAD
44  2004 Renal insufficiency as an independent predictor of mortality among women with heart failure. ACE, CI, CrCl, HF, HR
45  2004 Statin use and stroke outcomes in the Heart and Estrogen-Progestin Replacement Study (HERS). RH
46  2004 [Role of hormone replacement therapy in the prevention and treatment of menopausal osteoporosis]. WHI
47  2003 Alternate options to hormone replacement therapy for osteoporosis. ---
48  2003 Counseling patients who elect to discontinue hormone therapy. WHI
49  2003 Differences in medical care and disease outcomes among black and white women with heart disease. CHD
50  2003 Hormone therapy in menopause: the plot thickens. ET, HT, WHI
51  2003 Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). CHD, HDL-C, LDL-C, RH
52  2003 Menopause in crisis post-Women's Health Initiative? A view based on personal clinical experience. WHI
53  2003 Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. ---
54  2003 Soy foods and soybean isoflavones and menopausal health. CHD, WHI
55  2003 [Aerodiol: the efficacy and tolerability of intranasal estrogen administration. An overview]. ER, WHI
56  2002 Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). CHD, CI, RH
57  2002 Clinical cardiovascular studies of hormone replacement therapy. CAD, HRT, WHISP
58  2002 Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease: HERS B-mode substudy. IMT
59  2002 Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. ---
60  2002 Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease. ERA, HRT, OR, VTEs
61  2002 Hormone replacement in postmenopausal women: impact of progestogens on autonomic tone and blood pressure regulation. BP, HR, HRT, HRV
62  2002 Hostility predicts recurrent events among postmenopausal women with coronary heart disease. CHD
63  2002 Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). CI, RH
64  2002 Postmenopausal hormone replacement therapy: scientific review. CHD, CI, HR, HRT, RRs, WHI
65  2002 Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. ---
66  2002 Statin therapy, cardiovascular events, and total mortality in the Heart and Estrogen/Progestin Replacement Study (HERS). CI, HRT, RH
67  2002 Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. CHD
68  2002 Vasculoprotective effects of oestrogens. ---
69  2001 Adherence to screening guidelines for breast and cervical cancer in postmenopausal women with coronary heart disease: an ancillary study of volunteers for hers. BSE, CHD
70  2001 Comparative cardiovascular effects of different progestins in menopause. SERMs
71  2001 Debate: The slippery slope of surrogate outcomes. ---
72  2001 Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study. ---
73  2001 Effects of hormone replacement therapy on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). ---
74  2001 Heart disease in women. ERA
75  2001 Hormonal and Nonhormonal Therapies for the Postmenopausal Woman: What is the Evidence for Cardioprotection? ERA, RUTH
76  2001 Hormone replacement therapy for prevention of coronary heart disease: current evidence. ---
77  2001 Hormone replacement therapy in clinical cardiology. CHD
78  2001 Postmenopausal hormone replacement therapy and the vascular wall: epidemiology and clinical studies. CVD, HRT
79  2001 Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). RH
80  2001 Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study. ---
81  2001 Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. CHD, CI, RH
82  2001 Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. CI, RH
83  2001 The effect of continuous combined hormone replacement therapy on arterial reactivity in postmenopausal women with established angina pectoris. ---
84  2001 The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. OA, WOMAC
85  2001 The incidence of unrecognized myocardial infarction in women with coronary heart disease. ---
86  2001 The need for continuing education of the prescriber. HRT
87  2000 Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. CHD, CI, RHs
88  2000 Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women. CHD, ERT, HRT
89  2000 Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate. CAD, HRT
90  2000 Hormone replacement therapy and cardiovascular risk. ---
91  2000 HRT and cardiovascular disease. CHD, HRT, RCTs
92  2000 Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study. CAD, HRT
93  2000 Preserving cardiovascular benefits of hormone replacement therapy. MP, MPA, PEPI
94  2000 The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective--results not very surprising. ---
95  2000 The Heart and Estrogen/Progestin Replacement Study: what have we learned and what questions remain? CHD, HDL, HRT, LDL
96  2000 The positive predictive value of cervical smears in previously screened postmenopausal women: the Heart and Estrogen/progestin Replacement Study (HERS). ---
97  1999 Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection. ---
98  1999 Cardiovascular pharmacology of hormone replacement therapy. HRT
99  1999 Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection. CAD, HRT, NO, SERM
100  1999 Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. BMI, CI, OR, SD